Grant: Master's Award: Canada Graduate Scholarships
University of Alberta
$17,500.00
Development of a Binding Induced Strand Displacement Assay to Detect HER2
FY 2014-15
Summary
Development of a Binding Induced Strand Displacement Assembly to Detect HER2
Breast cancer affects many people worldwide. A particularly aggressive form of breast cancer is called HER2 positive, which is characterised by a protein, called HER2 (human epidermal growth factor receptor 2), that is produced in increased amounts in these patients relative to healthy individuals. Some forms of HER2 positive breast cancers are resistant to the current treatment, trastuzumab (Herceptin). Studies have found that weekly monitoring of HER2 concentrations in blood samples of patients undergoing trastuzumab treatment can predict if the treatment is working or if the cancer is resistant. This information can help physicians to adjust the type of treatment for better success in terms of patient survival and decreased cancer recurrence. The current laboratory test for blood detection of HER2 is labour intensive, time consuming, and can be costly if used for weekly monitoring.
The goal of this project is to design a new test that is inexpensive, easy to perform, and sensitive to detect HER2. This study will be using novel DNA technology to detect HER2 in which the presence of HER2 triggers a series of synthetic DNA binding reactions. This leads to the generation of a signal proportional to the concentration of HER2. This new assay technology will enable the detection of HER2 to be more cost effective, easier, and faster. The increased sensitivity for HER2 detection will contribute to better management of HER2 positive breast cancer.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
331588
Name
Newbigging Ashley M
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Development of a Binding Induced Strand Displacement Assay to Detect HER2
Programtype2
Studentship Programs
Orgnameinp2
University of Alberta
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Aptamers; Bioanalytical Chemistry; Breast Cancer; Clinical Laboratory Tests; Diagnostic Testing; Dna; Her2/Erbb2; Method Development; Nanotechnology; Nucleotides
Abstract
Development of a Binding Induced Strand Displacement Assembly to Detect HER2
Breast cancer affects many people worldwide. A particularly aggressive form of breast cancer is called HER2 positive, which is characterised by a protein, called HER2 (human epidermal growth factor receptor 2), that is produced in increased amounts in these patients relative to healthy individuals. Some forms of HER2 positive breast cancers are resistant to the current treatment, trastuzumab (Herceptin). Studies have found that weekly monitoring of HER2 concentrations in blood samples of patients undergoing trastuzumab treatment can predict if the treatment is working or if the cancer is resistant. This information can help physicians to adjust the type of treatment for better success in terms of patient survival and decreased cancer recurrence. The current laboratory test for blood detection of HER2 is labour intensive, time consuming, and can be costly if used for weekly monitoring.
The goal of this project is to design a new test that is inexpensive, easy to perform, and sensitive to detect HER2. This study will be using novel DNA technology to detect HER2 in which the presence of HER2 triggers a series of synthetic DNA binding reactions. This leads to the generation of a signal proportional to the concentration of HER2. This new assay technology will enable the detection of HER2 to be more cost effective, easier, and faster. The increased sensitivity for HER2 detection will contribute to better management of HER2 positive breast cancer.
Competitiondate
201412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Newbigging, Ashley M
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~